Genetron Health announces strategic partnership with JD Health to create innovative solutions for full-cycle cancer management (Genetron Health Press Release)
"Genetron Holdings Limited...today announced a strategic partnership with JD Health, a subsidiary of JD.com, Inc., and the largest online healthcare platform in China. The two companies aim to create innovative solutions for full-cycle cancer management...The Company will cooperate with JD Health to cover early cancer screening, molecular profiling, therapy selection, and drug resistance monitoring, leveraging the Company’s HCCscreen™ liquid biopsy product for hepatocellular carcinoma and its NMPA-approved 8-gene lung cancer detection kit...This agreement marks Genetron Health’s implementation of an online healthcare platform as the fourth commercialization channel for HCCscreen™, in addition to its three existing channels: medical examination centers, public health projects, and hospitals. The partnership also reflects JD Health’s goal to help manage cancer across all stages for its customers."